SalpeterSR, BuckleyJS, BuckleyNS, BrueraE: The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: A preliminary report. J Palliat Med, 2015; 18:114–119.
2.
EntrenaJM, CobosEJ, NietoFR, et al.: Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: Role of sigma-1 receptors. Psychopharmacology (Berl), 2009; 205:21–33.
3.
CobosEJ, del PozoE, BaeyensJM: Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells. J Neurochem, 2007; 102:812–825.
4.
IshiwataK, OdaK, SakataM, et al.: A feasibility study of [11C]SA4503-PET for evaluating sigma1 receptor occupancy by neuroleptics: The binding of haloperidol to sigma1 and dopamine D2-like receptors. Ann Nucl Med, 2006; 20:569–573.
5.
Rodríguez-MuñozM, Sánchez-BlázquezP, Herrero-LabradorR, et al.: The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control. Antioxid Redox Signal, 2015; 22:799–818.
6.
Vidal-TorresA, de la PuenteB, RocasalbasM, et al.: Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects. Eur J Pharmacol, 2013; 711:63–72.
7.
Sánchez-FernándezC, NietoFR, González-CanoR, et al.: Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptors. Neuropharmacology, 2013; 70:348–358.
